vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and IMAX CORP (IMAX). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $125.2M, roughly 1.5× IMAX CORP). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs 0.5%, a 0.4% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 23.7%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 25.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
FOLD vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $125.2M |
| Net Profit | $1.7M | $637.0K |
| Gross Margin | 85.7% | 57.6% |
| Operating Margin | 8.6% | 19.3% |
| Net Margin | 0.9% | 0.5% |
| Revenue YoY | 23.7% | 35.1% |
| Net Profit YoY | -88.5% | -88.0% |
| EPS (diluted) | $0.00 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $125.2M | ||
| Q3 25 | $169.1M | $106.7M | ||
| Q2 25 | $154.7M | $91.7M | ||
| Q1 25 | $125.2M | $86.7M | ||
| Q4 24 | $149.7M | $92.7M | ||
| Q3 24 | $141.5M | $91.5M | ||
| Q2 24 | $126.7M | $89.0M | ||
| Q1 24 | $110.4M | $79.1M |
| Q4 25 | $1.7M | $637.0K | ||
| Q3 25 | $17.3M | $20.7M | ||
| Q2 25 | $-24.4M | $11.3M | ||
| Q1 25 | $-21.7M | $2.3M | ||
| Q4 24 | $14.7M | $5.3M | ||
| Q3 24 | $-6.7M | $13.9M | ||
| Q2 24 | $-15.7M | $3.6M | ||
| Q1 24 | $-48.4M | $3.3M |
| Q4 25 | 85.7% | 57.6% | ||
| Q3 25 | 88.5% | 63.1% | ||
| Q2 25 | 90.2% | 58.5% | ||
| Q1 25 | 90.7% | 61.4% | ||
| Q4 24 | 90.1% | 52.2% | ||
| Q3 24 | 90.6% | 55.8% | ||
| Q2 24 | 91.1% | 49.4% | ||
| Q1 24 | 87.7% | 59.3% |
| Q4 25 | 8.6% | 19.3% | ||
| Q3 25 | 20.3% | 27.2% | ||
| Q2 25 | -6.1% | 15.6% | ||
| Q1 25 | -6.3% | 19.3% | ||
| Q4 24 | 10.7% | 10.3% | ||
| Q3 24 | 15.3% | 21.2% | ||
| Q2 24 | 11.8% | 3.2% | ||
| Q1 24 | -25.1% | 15.3% |
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 10.2% | 19.4% | ||
| Q2 25 | -15.8% | 12.3% | ||
| Q1 25 | -17.3% | 2.7% | ||
| Q4 24 | 9.8% | 5.7% | ||
| Q3 24 | -4.8% | 15.2% | ||
| Q2 24 | -12.4% | 4.0% | ||
| Q1 24 | -43.9% | 4.1% |
| Q4 25 | $0.00 | $0.02 | ||
| Q3 25 | $0.06 | $0.37 | ||
| Q2 25 | $-0.08 | $0.20 | ||
| Q1 25 | $-0.07 | $0.04 | ||
| Q4 24 | $0.05 | $0.09 | ||
| Q3 24 | $-0.02 | $0.26 | ||
| Q2 24 | $-0.05 | $0.07 | ||
| Q1 24 | $-0.16 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $151.2M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $337.9M |
| Total Assets | $949.9M | $894.0M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $151.2M | ||
| Q3 25 | $263.8M | $143.1M | ||
| Q2 25 | $231.0M | $109.3M | ||
| Q1 25 | $250.6M | $97.1M | ||
| Q4 24 | $249.9M | $100.6M | ||
| Q3 24 | $249.8M | $104.5M | ||
| Q2 24 | $260.1M | $91.6M | ||
| Q1 24 | $239.6M | $81.0M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $337.9M | ||
| Q3 25 | $230.4M | $349.5M | ||
| Q2 25 | $204.3M | $320.4M | ||
| Q1 25 | $193.6M | $299.5M | ||
| Q4 24 | $194.0M | $299.5M | ||
| Q3 24 | $178.8M | $289.4M | ||
| Q2 24 | $132.5M | $267.2M | ||
| Q1 24 | $130.7M | $258.8M |
| Q4 25 | $949.9M | $894.0M | ||
| Q3 25 | $868.8M | $889.6M | ||
| Q2 25 | $815.3M | $868.6M | ||
| Q1 25 | $789.8M | $848.3M | ||
| Q4 24 | $785.0M | $830.4M | ||
| Q3 24 | $786.6M | $847.6M | ||
| Q2 24 | $749.5M | $827.4M | ||
| Q1 24 | $721.8M | $824.1M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $29.4M |
| Free Cash FlowOCF − Capex | $16.0M | $28.0M |
| FCF MarginFCF / Revenue | 8.6% | 22.3% |
| Capex IntensityCapex / Revenue | 0.2% | 1.1% |
| Cash ConversionOCF / Net Profit | 9.62× | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $29.4M | ||
| Q3 25 | $35.7M | $67.5M | ||
| Q2 25 | $-26.5M | $23.2M | ||
| Q1 25 | $7.8M | $7.0M | ||
| Q4 24 | $-3.9M | $11.5M | ||
| Q3 24 | $-23.0M | $35.3M | ||
| Q2 24 | $22.7M | $35.0M | ||
| Q1 24 | $-29.7M | $-11.0M |
| Q4 25 | $16.0M | $28.0M | ||
| Q3 25 | $35.3M | $64.8M | ||
| Q2 25 | $-28.9M | $20.9M | ||
| Q1 25 | $7.5M | $5.3M | ||
| Q4 24 | $-4.2M | $6.9M | ||
| Q3 24 | $-23.3M | $34.2M | ||
| Q2 24 | $21.6M | $33.5M | ||
| Q1 24 | $-31.5M | $-12.1M |
| Q4 25 | 8.6% | 22.3% | ||
| Q3 25 | 20.9% | 60.7% | ||
| Q2 25 | -18.7% | 22.8% | ||
| Q1 25 | 6.0% | 6.1% | ||
| Q4 24 | -2.8% | 7.4% | ||
| Q3 24 | -16.5% | 37.3% | ||
| Q2 24 | 17.0% | 37.6% | ||
| Q1 24 | -28.5% | -15.3% |
| Q4 25 | 0.2% | 1.1% | ||
| Q3 25 | 0.2% | 2.6% | ||
| Q2 25 | 1.6% | 2.6% | ||
| Q1 25 | 0.2% | 1.9% | ||
| Q4 24 | 0.2% | 5.0% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.9% | 1.8% | ||
| Q1 24 | 1.6% | 1.4% |
| Q4 25 | 9.62× | 46.11× | ||
| Q3 25 | 2.06× | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | -0.27× | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | — | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
